Search

HONG KONG, GERMANTOWN, Md. and SUZHOU, China: Sirnaomics has issued the following news release: Sirnaomics Ltd. (the 'Company', Stock Code: 2257.HK, together with its subsidiaries, the 'Group' or 'Sirnaomics'), a [...]

MUNICH: Daiichi Sankyo Europe GmbH and Esperion Therapeutics, Inc. announce, that the Committee for Medicinal Products for Human Use of the European Medicines Agency (EMA) has adopted positive opinions for [...]

ANN ARBOR, Mich. and MUNICH: Esperion Therapeutics, Inc. has issued the following news release: Daiichi Sankyo Europe GmbH (hereafter, 'Daiichi Sankyo') and Esperion Therapeutics, Inc. jointly announced today, that the [...]

DUBLIN: Research and Markets has issued the following news release: The 'Global Dyslipidemia Drugs Market by Drug Class, By Indication, by Distribution Channel, and By Region' report has been added [...]

Pune: Growth Plus Reports has issued the following news release: According to the latest report published by Growth Plus Reports, the global Hypercholesterolemia Treatment Market is expected to clock US$ [...]

WILMINGTON: Transparency Market Research has issued the following news release: The global cardiovascular drugs market was valued at US$ 142.8 billion in 2022. The market is expected to expand at [...]

Ottawa: The global cardiovascular drugs market size accounted for USD 144.11 billion in 2023, and grew to USD 149.99 billion in 2024, According to Precedence Research. The U.S. cardiovascular drugs [...]

DUBLIN: Jazz Pharmaceuticals plc has issued the following news release: Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced new data that examine the comorbid risk of cardiovascular disease in patients with [...]

LONDON: As per The Business Research Company's Atherosclerosis Drugs Global Market Report 2023, the global atherosclerosis drugs market is poised for significant growth in 2023, with a projected value of [...]

Fort Collins, Colorado: DataHorizzon Research has issued the following news release: According to DataHorizzon Research, the cardiovascular drugs market size was valued at USD 147.7 Billion in 2022 and is [...]

New York: The sodium-dependent glucose cotransporter 2 (SGLT2) market has seen significant growth due to the COVID-19 pandemic, which has weakened the immune system of people with diabetes. Diabetic medicine [...]

MONTREAL: Montreal Heart Institute has issued the following press release: The Montreal Heart Institute (MHI) welcomes the approval by the United States Food and Drug Administration (FDA) of colchicine for [...]

SUNNYVALE: BioCardia, Inc. has issued the following press release: BioCardia(r), Inc. [Nasdaq: BCDA], a developer of cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases has made [...]

The Covid pandemic has exacerbated the challenges that people living with NCDs face in accessing essential medicines, according to a new report published by the World Health Organisation (WHO). The [...]

Douglas: Douglas Insights has issued the following press release: The pharmaceutical drugs Industry takes the initiative in research, development, production, and the consequent distribution of drugs all over the world. [...]

Dublin: Research and Markets has issued the following press release: The 'Computer-Aided Drug Discovery Market By Type, By Therapeutic Area, By End User: Global Opportunity Analysis and Industry Forecast, 2021-2030' [...]

Newark: The Brainy Insights has issued the following press release: Atherosclerosis drugs market size from USD 45.55 billion to USD 55.19 billion in 8 years: The increasing prevalence of cardiovascular [...]

New York: Persistence Market Research has issued the following press release: The global hypercholesterolemia treatment market is anticipated to grow from a value of US$ 27 Bn in 2022 to [...]

NEW YORK: Growth Plus Reports has issued the following news release: The Global Cardiovascular Drugs Market is expected to clock US$ 69.23 billion by 2030, according to the latest report [...]

CAMBRIDGE: Verve Therapeutics has issued the following news release: Verve Therapeutics, a biotechnology company pioneering a new approach to the care of cardiovascular disease with single-course gene editing medicines, reported [...]

Dublin: Research and Markets has issued the following press release: The 'Global Cardiovascular Drugs Market (2021-2026) by Drug Type, Disease Indications, Distribution Channel, Geography, Competitive Analysis and the Impact of [...]

DUBLIN: Research and Markets has issued the following news release: The 'Global Cardiovascular Drugs Market (2021-2026) by Drug Type, Disease Indications, Distribution Channel, Geography, Competitive Analysis and the Impact of [...]

CAMBRIDGE: Verve Therapeutics has issued the following news release: Verve Therapeutics, Inc., (Nasdaq: VERV), a biotechnology company pioneering a new approach to the care of cardiovascular disease with single-course gene [...]

Netherlands: Koninklijke Philips NV has issued the following press release: Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced North American availability of new innovations [...]

Amsterdam, the Netherlands: Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced North American availability of new innovations in its portfolio of cardiology solutions designed [...]

DUBLIN: Research and Markets has issued the following news release: The 'India Active Pharmaceutical Ingredients Market, By Method of Synthesis (Synthetic v/s Biological), By Source (Contact Manufacturing Organizations v/s In-house [...]

MALVERN, Pa.: Shifa Biomedical Corporation has issued the following news release: Shifa Biomedical Corporation (Shifa), a drug discovery company developing an oral small molecule PCSK9/low density lipoprotein-cholesterol receptor (LDLR) antagonist, [...]

CAMBRIDGE, Mass.: Verve Therapeutics has issued the following news release: Verve Therapeutics, a biotech company pioneering a new approach to the care of cardiovascular disease with single-course gene editing medicines, [...]

Luxembourg: Public Health Institution Specialized Hospital for Prevention, Treatment and Rehabilitation of Cardiovascular Diseases - Ohrid has issued contract notice/solicitation for 'North Macedonia-Ohrid: Angiography supplies' Reference no: 2021/S 067-173968 Posted [...]

DUBLIN: Research and Markets has issued the following news release: The 'Burger's Medicinal Chemistry, Drug Discovery and Development, 8 Volume Set. Volumes 1 - 8' book from John Wiley and [...]

Luxembourg: Public Health Institution Specialized Hospital for prevention, treatment and rehabilitation of cardiovascular diseases has issued contract notice/solicitation for 'North Macedonia-Ohrid: Angiography supplies' Reference no: 2021/S 065-169647 Posted on: 02/04/2021 [...]

LAVAL: Altasciences have conducted preclinical studies for Verve Therapeutics that supports the development and advancement of Verve's gene editing approach to treating cardiovascular diseases. Altasciences' Seattle team performed intravenous preclinical [...]

PALO ALTO: Eiger BioPharmaceuticals, Inc. has issued the following news release: Eiger BioPharmaceuticals, Inc. (Nasdaq:EIGR), focused on the development and commercialization of targeted therapies for serious rare and ultra-rare diseases, [...]

Luxembourg: Public Health Institution Specialized hospital for prevention, treatment and rehabilitation of cardiovascular diseases - Ohrid has issued contract notice/solicitation for 'North Macedonia-Ohrid: Angiography room' Reference no: 2020/S 124-305073 Posted [...]

BOSTON: IDTechEx has issued the following news release: Cardiovascular disease (CVD) is the leading cause of death worldwide, with over 17 million per year according to the World Health Organisation. [...]

Ann Arbor: Esperion Therapeutics, Inc. has issued the following press release: Esperion (NASDAQ:ESPR) today announced that the U.S. Food and Drug Administration (FDA) approved NEXLIZET (bempedoic acid and ezetimibe) tablet, [...]

Luxembourg: Public Health Institution Specialized Hospital for prevention, treatment and rehabilitation of cardiovascular diseases -- Ohrid has issued contract notice/solicitation for 'North Macedonia-Ohrid: Angiography supplies' Reference no: 2019/S 153-378732 Posted [...]

Luxembourg: Public Health Institution Institute for prevention, treatment and rehabilitation of cardiovascular diseases -- Ohrid Postal has issued contract notice/solicitation for 'North Macedonia-Ohrid: Angiography supplies' Reference no: 2019/S 148-365987 Posted [...]

London: Circassia Pharmaceuticals PLC has issued the following press release: Circassia Pharmaceuticals PLC on Friday said the US Food & Drug Administration approved Tudorza's supplemental new drug application for the [...]

PALM BEACH: Financialnewsmedia.com has issued the following news release: Financialnewsmedia.com News Commentary Biotech and Big Pharma companies are facing new realities, prospects and success measures in today's dynamic cardiovascular disease [...]

Macedonia:Public Health Institution Institute for prevention, treatment and rehabilitation of cardiovascular diseases - Ohrid has issued requirement for 'Former Yugoslav Republic of Macedonia-Ohrid: Petroleum products, fuel, electricity and other sources [...]

Brussels: European AIDS Treatment Group has issued the following press release: People with hepatitis C in the United States are at least three times more likely to smoke than the [...]

Ohrid: Public Health Institution Institute for prevention, treatment and rehabilitation of cardiovascular diseases - Ohrid has issued requirement for 'Former Yugoslav Republic of Macedonia-Ohrid: Pharmaceutical products' Former Yugoslav Republic of [...]

Ohrid: Public Health Institution Institute for prevention, treatment and rehabilitation of cardiovascular diseases - Ohrid has issued requirement for 'Former Yugoslav Republic of Macedonia-Ohrid: Laboratory, optical and precision equipments (excl. [...]

Wicklow: Takeda has issued the following press release: Takeda Pharmaceutical Company Limited (TSE: 4502) and Cardurion Pharmaceuticals today announced the creation of a new cardiovascular development partnership. Cardurion, a recently [...]

Santa Ana, CA: Following is the Profile of Dr. Alyn Anderson, MD (Internal Medicine and Cardiovascular Disease) of CITrials: Dr. Anderson is a Patients Choice winner for 2010- 2012 and [...]

Santa Ana, CA: Following is the Profile of Dr. Alyn Anderson, MD (Internal Medicine and Cardiovascular Disease) of CITrials: Dr. Anderson is a Patients Choice winner for 2010- 2012 and [...]

Luxembourg: Public Health Institution Institute for prevention, treatment and rehabilitation of cardiovascular diseases -- Ohrid has issued requirement for 'Former Yugoslav Republic of Macedonia-Ohrid: Food, beverages, tobacco and related products' [...]

Luxembourg: Public Health Institution Institute for prevention, treatment and rehabilitation of cardiovascular diseases -- Ohrid has issued requirement for 'Former Yugoslav Republic of Macedonia-Ohrid: Angiography supplies' Reference no: 111145-2017 Posted [...]

Indianapolis: Eli Lilly and Company has issued the following press release: The U.S. Food and Drug Administration (FDA) approved supplemental New Drug Applications for three type 2 diabetes medicines within [...]